Effect of Remote Pharmaceutical Care on the Efficacy and Safety of Medication in Patients with Newly-Diagnosed Hypertension
Objective To investigate the effect of remote pharmaceutical care on the efficacy and safety of medication in patients with newly-diagnosed hypertension.Methods A total of 355 patients with newly-diagnosed hypertension at the Zhongshan Hospital,Fudan University from August 2020 to June 2021 were selected and divided into the control group(178 cases)and the intervention group(177 cases)by the random number table method.The patients in the two groups were given conventional medical service,on this basis,the patients in the intervention group were given remote pharmaceutical care,including receiving medication guidance forms and follow-up once a week via phone or WeChat by clinical pharmacists.After six months,the indexes related to medication efficacy,adherence and safety between the two groups were compared.Results The diastolic blood pressure(after correction)in the intervention group was significantly lower than that in the control group[(77.54±0.57)mmHg vs.(85.00±0.56)mmHg,P<0.001],the standard-reaching rate of blood pressure was significantly higher than that in the control group(84.43%vs.69.41%,P = 0.001).The medication adherence score in the intervention group was significantly better than that in the control group[(1.78±0.69)points vs.(2.05±0.76)points,P = 0.001],the drug understanding score was significantly better than that in the control group[(1.45±0.65)points vs.(2.77±0.44)points,P<0.001].The incidence of adverse reactions in the intervention group was significantly lower than that in the control group(13.17%vs.22.94%,P = 0.020),the incidence of readmission was significantly lower than that in the control group(2.99%vs.14.71%,P = 0.002).Conclusion Remote pharmaceutical care can effectively improve the efficacy,adherence and safety of medication in patients with newly-diagnosed hypertension.